In the BioHarmony Drug Report Database
Penicillin g benzathine
Bicillin, Bicillin L-a, Permapen (penicillin g benzathine) is a small molecule pharmaceutical. Penicillin g benzathine was first approved as Bicillin on 1982-01-01. It is used to treat actinomycosis, anthrax, bacterial infections, bacterial skin diseases, and botulism amongst others in the USA.
Trade Name
|
Bicillin, Bicillin L-a, Permapen |
|---|---|
Common Name
|
penicillin g benzathine |
ChEMBL ID
|
CHEMBL3989515 |
Indication
|
actinomycosis, anthrax, bacterial infections, bacterial skin diseases, botulism, diphtheria, empyema, endocarditis, erysipelothrix infections, escherichia coli infections, gonorrhea, listeriosis, meningococcal infections, pasteurella infections, pericarditis, pneumococcal infections, rat-bite fever, respiratory tract infections, rheumatic fever, salmonella infections, staphylococcal infections, syphilis, tetanus, urinary tract infections |
Drug Class
|
Penicillins |
Image (chem structure or protein)